tech

Harris strategically realigns into three business segments

business, commercial, communications, government, harris, information, it, market, networks, restructure, services, systems, tech, technology

Harris has strategically realigned its operating businesses to provide increased market focus and address the fast-growing global market for integrated communications and information technology and services. The realignment will e

By Stephanie Shyu
sshyu@fnno.com

UBS Raises Its PT For Dupont Fabros Technology

Published on Mon, 03/07/2011 - 15:39
By Stephanie Shyu in General Interest, DFT, ubs, analyst, bank, consensus, dft, dupont fabros, firm, nyse, price, rating, stock, tech, technology, ubs, wall street, Analyst Actions

DuPont Fabros Technology has a potential upside of 15.3% based on a current price of $22.95 and an average consensus analyst price target of $26.46.

DuPont Fabros Technology is currently above its 50-day moving average (MA) of $22.19 and should find resistance at its 200-day MA of $23.94.

analyst, bank, consensus, dft, dupont fabros, firm, nyse, price, rating, stock, tech, technology, ubs, wall street

UBS raised its price target for Dupont Fabros Technology (NYSE:DFT) to $22 from $20 and maintained its neutral rating on the company.

By Stephanie Shyu
sshyu@fnno.com

Western Digital to Acquire Hitachi Global Storage Technologies

Under the terms of the agreement, WD will acquire Hitachi GST for $3.5 billion in cash and 25 million WD common shares valued at $750 million.

acquisition, board, cash, cost, debt, directors, earnings, expense, global storage, hit, hitachi, innovation, john coyne, m&a, market, merger, nyse, r&d, shares, stock, subsidiary, tech, technologies, wdc, western digital

Western Digital (NYSE:WDC) and Hitachi, Ltd. (NYSE:HIT) announced today that they have entered into a definitive agreement whereby WD will acquire Hitachi Global Storage Technologies, a wholly-owned subsidiary of Hitachi, Ltd., in

By Stephanie Shyu
sshyu@fnno.com

Marina Biotech Gains 7.% After Getting Positive Product Data

Published on Wed, 03/02/2011 - 12:47
By Stephanie Shyu in General Interest, mrna, ascites, bio, cancer, disease, health, malignant, marina biotech, medical, mrna, patient, pharma, shares, stock, tech, treatment, News Update

Dr. Barry Polisky, Chief Scientific Officer at Marina, said in a statement: "These results further demonstrate the utility of our DiLA2 delivery technology for local administration."

Marina Biotech shares are up 7.47%, to $0.731.

ascites, bio, cancer, disease, health, malignant, marina biotech, medical, mrna, patient, pharma, shares, stock, tech, treatment

Shares of Marina Biotech (MRNA) are higher after company data was presented demonstrating significant knockdown of target mRNA in an orthotopic model of malignant ascites with its proprietary UsiRNA construct and DiLA2-based deliv

By Stephanie Shyu
sshyu@fnno.com

Apple Expected To Unveil New iPad At Today's Event In SF (AAPL,RIMM)

Analysts believe that the company will not have trouble maintaining its market-dominating position for the near term. The device surpassed the iPod in revenue contribution and is on track to eclipse the Mac line of computers by ne

Apple released its first iPad in April of last year.

aapl, analyst, apple, cali, california, computers, conference, devices, event, financial, ipad, ipod, laptop, mac, market, mot, motorola, nasdaq, nyse, research in motion, rim, rimm, samsung, san fran, san francisco, sf, steve jobs, tech

Apple (NASDAQ:AAPL) is expected to unveil its new iPad at an event in San Francisco today as competition comes from Motorola (NYSE:MOT), Samsung and Research in Motion (NASDAQ:RIMM), according to a Bloomberg report.

By Stephanie Shyu
sshyu@fnno.com

Agilent Acquires Biocius Life for Undisclosed Amount

Financial terms of the transaction were not disclosed.

Shares are up 0.045 to $42.11.

acquire, acquisitions, agilent, biocius, biopharma, biopharmaceutical, drug, financial, healthcare, life, market, medica, merger, pharma, pharmaceutical, science, shares, spectrometry, stock, tech, technologies, trade

Agilent Technologies (A) announced today that it has acquired Biocius Life Sciences, developer of RapidFir, a high-throughput mass spectrometry drug-screening platform for the pharmaceutical and biopharmaceutical markets.

By Stephanie Shyu
sshyu@fnno.com

Northrop Grumman awarded a contract for cyberspace operation

california, contract, cyber, cyberspace, engineering, military, naval, navy, northrop grumman, research, san diego, science, tech, technology, warfare, weapons

Northrop Grumman has been awarded a contract for cyberspace operations supporting the U.S. Navy's Space and Naval Warfare Systems Center Pacific (SSC Pacific) to provide cyberspace science, research, engineering and technology int

By Stephanie Shyu
sshyu@fnno.com

Allegheny Technologies Names Richard Harshman as CEO; Patrick Hassey to Retire

Allegheny shares are up 0.81% to $66.90.

allegheny, ati, ceo, cfo, chairman, company, coo, evp, harshman, incoming, l patrick hassey, management, outgoing, personnel, president, retire, richard, shares, stock, succeed, tech, technologies

Allegheny Technologies (ATI) announced Monday that President and COO Richard Harshman will replace Chairman and Chief Executive Officer, L. Patrick Hassey. The outgoing executive will retire on May 1. Harshman has been with the c

By Stephanie Shyu
sshyu@fnno.com

Micron Tech Up Fractionally, Expected to Benefit from iPad 2

aapl, apple, arm holdings, armh, cnbc, financial, hot stocks, ipad2, jim cramer, mad money, market, micron, mu, nasdaq, shares, show, skyworks solutions, stock, swks, tech, trade, tv

Nasdaq heavyweight Micron Technology, Inc. (MU) is up 0.52% Monday to $11.50. The stock is extending late Friday gains higher. Micron is benefiting from a mention by Jim Cramer on his CNBC Mad Money show. He counted Micron among s

By Stephanie Shyu
sshyu@fnno.com

Amazon Struggles Early After UBS Downgrade; Margin Squeeze Seen

The stock opened down $3.14 at $174.10 before adding back $1.22 to trade at $174.93. Still down 1.30%.

Analyst Brian Pitz dropped the stock to "neutral" from "buy," and lowered his price target to $180 from $195. He noted: "It now looks likely AMZN will need to invest in acquiring content, distribution deals, and technology.

amazon prime, amazone.com, amzn, analyst, brian pitz, costs, deals, downgrade, eps, financial, fiscal, margins, market, online, price, purchase, rating, retailer, revenue, shopping, stock, tech, trade

Amazon.com (AMZN) is down Monday, but moving off its earlier low. The online retailer was downgraded by UBS this morning over concerns that increasing costs will put new pressure on margins.

By Stephanie Shyu
sshyu@fnno.com

Latest News from FNNO

Earnings Look Back: Comcast Is Up 3.1% S...

When Comcast (NASDAQ:CMCSK) reported earnings 17 days ago on May 1st, 2013, analysts, o ...

Earnings Flashback: Since Reporting Quar...

A week ago on May 6th, 2013 Liberty Global (NASDAQ:LBTYA) reported earnings and analyst ...

Earnings Look Back: Kelly Services Is Up...

When Kelly Services (NASDAQ:KELYA) reported earnings a week ago on May 8th, 2013, analy ...

Liberty Media Earnings Review: 10 Days a...

When Liberty Media (NASDAQ:LINTA) reported earnings a week ago on May 8th, 2013, analys ...

Central Garden and Pet Earnings Hindsigh...

A week ago on May 8th, 2013 Central Garden and Pet (NASDAQ:CENTA) reported earnings and ...

Comcast Earnings Review: 17 Days after A...

When Comcast (NASDAQ:CMCSA) reported earnings 17 days ago on May 1st, 2013, analysts, o ...

Earnings Flashback: Since Reporting Quar...

A week ago on May 7th, 2013 Discovery Communications (NASDAQ:DISCA) reported earnings a ...

Jazz Pharmaceuticals Earnings In Retrosp...

11 days ago, on May 7th, 2013, Jazz Pharmaceuticals (NASDAQ:JAZZ) reported its earnings ...

Most Popular Video News